WallStreetZenWallStreetZen

NASDAQ: ADRX
Adarx Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Adarx Pharmaceuticals revenue was N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ADRX annual revenue was $3.4M, with Infinity% growth year-over-year.

ADRX revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when ADRX announces revenue.

ADRX Revenue History By Year

ADRX Yearly RevenueADRX RevenueADRX ChangeADRX Revenue Growth
2025-12-31$3.45MN/AN/A
2024-12-31$0.00N/AN/A

1 of 1

Adarx Pharmaceuticals Revenue FAQ

What was Adarx Pharmaceuticals's annual revenue growth in the past year?

As of Q3 2026, Adarx Pharmaceuticals's revenue has grown null year over year. Adarx Pharmaceuticals's revenue in the past year totaled N/A.

How much does Adarx Pharmaceuticals make in a year?

Adarx Pharmaceuticals's revenue by year for the past one years is:
  • Adarx Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $3.45 million, a Infinity% increase year over year.

What was Adarx Pharmaceuticals's revenue in 2025?

Adarx Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2025 was $3.45 million, a Infinity% increase year over year.

How much does Adarx Pharmaceuticals make in a day?

Based on Adarx Pharmaceuticals annual revenue for the past one years, ADRX makes an average of $9,449.32 per day.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.